In Chapter 10, “Deep Discovery,” author Eric Topol considers the marriage of omics and AI.

A small pilot study suggests the approach can identify effective treatments already approved for other cancers.

New techniques combine DNA, RNA, and protein information from single cells.

Big data and empirical approaches to understanding diseases provide a limited picture of pathogenesis.

Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

In 2017, scientists, regulators, and publishers clashed in a series of lawsuits, boycotts, mass resignations, and more.

A database of scientific journal titles has removed several OMICS titles for “publication concerns.”

A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.

Untargeted metabolic profiling implicates a new suite of metabolites that may be involved in nerve damage-induced pain.

There is definitely no shortage of technological innovation in the life sciences.

To the great scientific leaps witnessed during our first 25 years, and the game changers yet to come.

Three gene jockeys share their thoughts on past and future tools of the trade.

The European Commission takes a major step towards unraveling the secrets of human epigenetics.